Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Margaret M. Schweri"'
Publikováno v:
Journal of Medicinal Chemistry. 50:2718-2731
A series of threo-1-aza-3 or 4-substituted-5-phenyl[4.4.0]decanes (quinolizidines), which were envisioned as restricted rotational analogues (RRAs) of methylphenidate (MP), was synthesized and tested for inhibitory potency against [(3)H]WIN35,428, [3
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 301:527-535
As part of a project to develop treatment agents for cocaine abuse, (+/-)-threo-methylphenidate (TMP) and 11 analogs were characterized biochemically and behaviorally to assess their potential as anti-cocaine medications. The compounds contained aryl
Publikováno v:
European Journal of Medicinal Chemistry. 36:303-311
In order to make new analogs of the dopamine (DA) uptake inhibitor methylphenidate, a synthetic methodology based on the Blaise reaction was developed. The reaction between alpha-bromophenylacetic acid esters, zinc and alpha-cyano-omega-mesylates gav
Autor:
Margaret M. Schweri, Kikue S. Burnham, Liang Zhang, Stephan G. Holtzman, Abhay K. Deshpande, David M. Collard, Howard M. Deutsch
Publikováno v:
Journal of Medicinal Chemistry. 42:882-895
As part of a program to develop site-specific medications for cocaine abuse, a series of 2-(aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane derivatives was synthesized and tested for inhibitory potency in [3H]WIN 35,428 binding and [3H]dopami
Autor:
Howard M. Deutsh, Margaret M. Schweri, Quing Shi, Mark Froimowitz, Robert Glaser, Clifford George, Itay Adin, Kuo-Ming Wu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:1213-1218
N-methyl derivatives of methylphenidate and four analogs were synthesized and assayed for affinity at the dopamine transporter. The binding affinities of the N-methyl compounds were consistently lower by a factor ranging from 4 to 30 as compared with
Autor:
Margaret M. Schweri, Howard M. Deutsch
Publikováno v:
Life Sciences. 55:PL115-PL120
Both 3- and 4-substituted GBR 12783 derivatives were synthesized in an effort to create site-directed cocaine antagonists. The potencies of these compounds to inhibit stimulant ([3H]WIN 35,428) binding and synaptosomal [3H]dopamine uptake were determ
Publikováno v:
ChemInform. 27
Autor:
Qing Shi, Howard M. Deutsch, Milind Misra, Xiaocong Ye, Carol A. Venanzi, Zhanzhu Liu, Margaret M. Schweri, Wei Bu, Ewa Gruszecka-Kowalik
Publikováno v:
Bioorganicmedicinal chemistry. 18(20)
Complementary two-dimensional (2D) and three-dimensional (3D) Quantitative Structure–Activity Relationship (QSAR) techniques were used to derive a preliminary model for the dopamine transporter (DAT) binding affinity of 80 racemic threo-methylpheni
Publikováno v:
ChemInform. 32
Autor:
Heath H. Herman, James E. Colbert, Lydia C. Fowler, Sheldon W. May, Margaret M. Schweri, Philip A. Husain, Stanley H. Pollock
Publikováno v:
Journal of Medicinal Chemistry. 34:1082-1085
We have found that (R,S)-1-(phenylthio)-aminopropane (4a), a synthetic alternate substrate for the terminal enzyme of norepinephrine biosynthesis, dopamine beta-monooxygenase (DBM), is both an indirect sympathomimetic and a potent antihypertensive ag